欧盟国家癌症概况综合报告2025

EU Country Cancer Profiles EU Country Cancer Profiles SynthesisReport 2025 This work is published under the responsibility of the Secretary-General of the OECD andthe President ofthe European Commission. The opinions expressed and arguments employed herein do not necessarilyreflect the official views of the Member countries of the OECD or of the European Union. This document, as well as any data and map included herein, are without prejudice to the status of orsovereignty over any territory, to the delimitation of international frontiers and boundaries and to the nameof any territory, city or area. The names of countries and territories and maps used in this joint publication follow the practice of theOECD. Specific territorial disclaimers applicable to the OECD: Note by the Republic of Türkiye The information in this document with reference to “Cyprus” relates to the southern part of the Island. Thereis no single authority representing both Turkish and Greek Cypriot people on the Island. Türkiye recognisesthe Turkish Republic of Northern Cyprus (TRNC). Until a lasting and equitable solution is found within thecontext of the United Nations, Türkiye shall preserve its position concerning the “Cyprus issue”. Note by all the European Union Member States of the OECD and the European Union The Republic of Cyprus is recognised by all members of the United Nations with the exception of Türkiye.The information in thisdocument relates to the area under the effective control of the Government of theRepublic of Cyprus. Please cite this publication as: OECD/EuropeanCommission(2025),EU Country Cancer Profiles Synthesis Report 2025,OECDPublishing, Paris,https://doi.org/10.1787/20ef03e1-en. Photo credits: Cover design using image from © gmast3r/istockphoto.com. © OECD/European Union 2025. In the event of any discrepancy between the original work and anytranslated versions of this work, only the text of original work should be considered valid. Attribution4.0 International (CCBY4.0) This work is made available under the Creative Commons Attribution4.0 International licence.By using this work, you accept to be bound by the termsof this licence (https://creativecommons.org/licenses/by/4.0/). Attribution–you must cite the work. Translations–you must cite the original work, identify changes to the original and add the following text:In the event of any discrepancy between theoriginal work and the translation, only the text of original work should be considered valid. Adaptations–you must cite the original workand add the following text:This is an adaptation of an original work by the OECD and the EuropeanUnion. The opinions expressed and arguments employed in this adaptation should not be reported as representing the official views of the OECD or ofits Member countries or of the European Union. Third-party material–the licence does not apply to third-party material in the work. If using such material, you are responsible for obtaining permissionfrom the third party and for any claims of infringement. You must not use the OECD’s or the European Commission’s logo, visual identity or cover image without express permission or suggest the OECD orEuropean Commission endorses your use of the work. Any dispute arising under this licence shall be settled by arbitration in accordance with the Permanent Court of Arbitration (PCA) Arbitration Rules2012.The seat of arbitration shall be Paris (France). The number of arbitrators shall be one. Foreword Europe’s Beating Cancer Plan(EBCP)addresses the longstanding threatposed by cancer. One of thePlan’s ten flagship initiatives, the European Cancer Inequalities Registry assesses inequalities in cancer.Under this umbrella, the OECD and European Commission presentthissynthesis report, highlightingfindings from the 2025 Country Cancer Profiles. These country-specific assessments, authored by theOECD and the European Commission, provide the latest data and developments across the cancerspectrum, from prevention to survivorship in EU Member States, Iceland and Norway. The 2025 synthesis report brings to light four main messages. First, cancer is only growing as a publichealth concern in the EU, as the share of people under active treatment or living with a history of cancerexpands due to population ageing and notable decreases in cancer mortality. However, even with thereductions, mortality rates remain much higher among lower income countries in the EU, as well as amongmen and those with lower levels of education. Second, there is evidence of improvement on a numberof cancer risk factors in the EU over time, with thenotable exception of overweight and obesity, which are an increasing challenge. Smoking rates havedecreased in the vast majority of EUcountries. Trends in alcohol use show more variability by country,butpoint to an overall decrease at the EU level. However, even with substantial policy measures addressingthe intersecting risk factors of overweight, low physical